Intellectual Property

  • June 24, 2024

    Flag Football Co. Fights To Keep TM Dispute Alive

    A simmering feud over the national leadership of flag football within the U.S. has intensified in Texas federal court, with the organization challenging the group holding itself out as the sport's governing body urging the judge to keep the dispute alive.

  • June 24, 2024

    DC Circ. Backs Gov't Contractor Win In Fight With Ex-Worker

    The D.C. Circuit has backed a ruling that a former senior technical manager for government contractor Apprio Inc. breached a proprietary information agreement giving the rights of certain software he created over to the company.

  • June 24, 2024

    Research Co. Seeks Sanctions On Proud Boys Atty In IP Suit

    A Texas research firm pursuing copyright infringement claims against a group of defense attorneys who represented members of the Proud Boys wants one of the lawyers sanctioned for filing "a frivolous and groundless counterclaim" in the D.C. federal court litigation.

  • June 24, 2024

    Catching Up With Delaware's Chancery Court

    Amendments to Delaware's General Corporation Law topped the news out of the Court of Chancery again last week, as the hotly contested measure sailed through the state's legislature. Tesla and its shareholders continued their tug-of-war over attorney fees for Chancery litigation about Elon Musk's pay package, and new cases were filed involving biotechs, car rental companies, workout platforms, telecom towers, and a cargo ship fire in Brazil.

  • June 24, 2024

    High Court Passes On Religious Webcasters' Royalty Hike Suit

    The U.S. Supreme Court refused Monday to review the federal Copyright Royalty Board's latest hike in royalty rates webcasters must pay to play audio recordings, turning away a radio trade group's appeal challenging one of the increases on religious freedom and administrative procedure grounds.

  • June 24, 2024

    High Court To Review $46.6M Award Over 'Dewberry' TM Fight

    The U.S. Supreme Court on Monday granted a real estate development company's request to review a $46.6 million trademark infringement award that petitioners argued violated federal law by making its corporate affiliates responsible for the amount.

  • June 21, 2024

    Quinn Emanuel Rips Columbia's 'Utterly Meritless' Filing Bid

    Quinn Emanuel Urquhart & Sullivan LLP told the Federal Circuit on Friday that Columbia University's bid to introduce a former Norton Lifelock computer scientist's declaration claiming the company's former lawyers at the firm are lying about his refusal to testify in the school's decade-long $600 million patent case is "utterly meritless."

  • June 21, 2024

    Apple Won't Offer AI Tools In EU Due To Regulatory Concerns

    Apple confirmed Friday that the tech giant isn't planning on releasing new artificial intelligence features in the European Union this year due to "regulatory uncertainties" involving the bloc's new Digital Markets Act and the potential security risks that complying with the DMA could pose to Apple users.

  • June 21, 2024

    Drug Cos., IP Attys Back Cellect In High Court Efforts

    A petition by patent litigation outfit Cellect that is looking to persuade the U.S. Supreme Court to wade into a double patenting dispute has drawn support from even more lawyers as well as a handful of major drugmakers and small tech companies like Sonos.

  • June 21, 2024

    Drugmakers Decline To Drop Patent Listings After FTC Letters

    The eight pharmaceutical companies that the Federal Trade Commission warned in April may have improperly listed patents for its products in a key federal database have chosen not to remove any patents or otherwise alter their listings, according to a document released Friday.

  • June 21, 2024

    After Fed. Circ. Win, Bausch Sues Alvogen Over Drug Patents

    Bausch's Salix Pharmaceuticals has launched a lawsuit against Alvogen's Norwich Pharmaceuticals unit in a New Jersey federal court, claiming that its planned generic version of Xifaxan, a blockbuster diarrhea and brain disorder drug, infringes a set of patents.

  • June 21, 2024

    Chicago Cubs Cry Foul Over Rooftop Owner's Ticket Sales

    The Chicago Cubs have sued the owner of a rooftop venue with a view of Wrigley Field, accusing him of selling tickets for Cubs games and other events at the stadium despite having an expired license to do so and profiting off the infringement of the Cubs' intellectual property rights.

  • June 21, 2024

    In Ruling By Albright, Fed. Circ. Revives Apple Patent Review

    The Federal Circuit on Friday vacated a Patent Trial and Appeal Board ruling that Apple failed to prove the invalidity of several claims of an Omni MedSci Inc. heart rate monitor patent, in the first decision by the appeals court authored by U.S. District Judge Alan Albright of the Western District of Texas.

  • June 21, 2024

    Treasury Unveils Rules Curtailing Outbound Tech Investments

    The U.S. Department of the Treasury on Friday proposed rules to implement President Joe Biden's executive order aimed at restricting American investments in certain technologies that China is developing, including artificial intelligence systems, that are deemed threats to national security.

  • June 21, 2024

    Fed. Circ. Backs DraftKings, FanDuel Alice Win Over GPS IP

    A New Jersey federal judge rightly dismissed Beteiro LLC's infringement suits against DraftKings, FanDuel and other gaming companies after finding its GPS patents can't meet patentability requirements, the Federal Circuit held Friday.

  • June 21, 2024

    5th Circ. Undoes Part Of TM Ruling In Appliance Stores' Fight

    The Fifth Circuit on Friday partly reversed a Texas federal court's conclusion that a San Antonio appliance company infringed two marks of rival business Appliance Liquidation Outlet LLC, finding that while the name of the store is a valid trademark, the shorthand "Appliance Liquidation" is not.

  • June 21, 2024

    Pay-For-Delay Drug Case Not Time-Barred, UK Tribunal Says

    The U.K. Competition Appeal Tribunal refused Friday to apply a much more restrictive statute of limitations that would toss government claims that Danish pharmaceutical company Lundbeck Ltd. and generic drug manufacturers anticompetitively agreed to delay generic competition to an antidepressant.

  • June 21, 2024

    Ex-CEO Found Liable For $1 Now Seeks Atty Fees For Del. Suit

    The ex-CEO of a biopharma company who was found liable in 2021 for breaching his fiduciary duties but ordered to pay just $1 in damages after Delaware's Court of Chancery found that no real harm had been done is now suing for his attorney's fees and court costs.

  • June 21, 2024

    Zoom Latest Tech Giant Accused Of Infringing NM Co.'s Patent

    A New Mexico company has hit videoconferencing behemoth Zoom with a patent suit in Colorado federal court, alleging that Zoom is knowingly infringing a patent for identifying voices across multiple telephone networks.

  • June 21, 2024

    Kona Ice Nabs $533K In Toppings Dispenser Patent Trial

    A Florida federal jury has come to the conclusion that a small shaved ice franchise from Boca Raton owes the Kona Ice brand a little over half a million dollars for infringing a patent covering a "liquid toppings dispensing system."

  • June 21, 2024

    Skiplagged Removes Motion After Judge's Rebuke

    Airfare search engine Skiplagged Inc. has settled its differences with American Airlines in a discovery dispute that prompted an "exasperated" Texas federal judge to order the parties to mediation, saying both sides had addressed the concerns that prompted Skiplagged to file for a protective order.

  • June 21, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen JD Wetherspoon sue a Welsh pub over its name in the Intellectual Property Court, ex-professional boxer Amir Khan and his wife file libel action against an influencer, the Performing Right Society hit with a competition claim over music licensing, and Manolete Partners bring action against the directors of a bust investment firm. Here, Law360 looks at these and other new claims in the U.K.

  • June 20, 2024

    Patent Owners, Challengers Spar Over PTAB Rule Proposal

    The U.S. Patent and Trademark Office's scaled-back package of Patent Trial and Appeal Board rules has drawn a mixed reaction from legal and industry groups, which offered praise and concern about both the proposal and the topics it does not address.

  • June 20, 2024

    'Jetflicks' Piracy Trial Results In 5 Convictions In Las Vegas

    Following a trial that stretched on for half a month, a federal jury in Las Vegas convicted a group of people who were accused of making more than $1 million running an illegal streaming website called "Jetflicks."

  • June 20, 2024

    Eli Lilly Launches Round Of Diabetes Drug Suits

    Eli Lilly on Thursday hit various compounding pharmacies and medical spas in five states and the District of Columbia with suits saying that they trick consumers into thinking that they sell Eli Lilly medications that treat diabetes and obesity when actually they are copycats and are untested by the U.S. Food and Drug Administration.

Expert Analysis

  • 8 Legal Issues Influencing Investors In The Creator Economy

    Author Photo

    The rapidly expanding digital creator economy — funding for which more than doubled in the U.S. in the first quarter — comes with its own set of unique legal issues investors must carefully consider before diving in, say Louis Lehot and Alan Pate at Foley & Lardner.

  • E-Discovery Quarterly: Recent Rulings On Text Message Data

    Author Photo

    Electronically stored information on cellphones, and in particular text messages, can present unique litigation challenges, and recent court decisions demonstrate that counsel must carefully balance what data should be preserved, collected, reviewed and produced, say attorneys at Sidley.

  • How Copyright Office AI Standards Depart From Precedent

    Author Photo

    The U.S. Copyright Office's recent departure from decades of precedent for technology-assisted works, and express refusal to grant protection to artificial intelligence-assisted works, may change as the dust settles around ancillary copyright issues for AI currently pending in litigation, says Kristine Craig at Hanson Bridgett.

  • IP Considerations For Companies In Carbon Capture Sector

    Author Photo

    As companies collaborate to commercialize carbon capture technologies amid massive government investment under the Infrastructure Investment and Jobs Act, a coherent intellectual property strategy is more important than ever, including proactively addressing and resolving questions about ownership of the technology, say Ashley Kennedy and James De Vellis at Foley & Lardner.

  • Does Expert Testimony Aid Preliminary IPR Responses?

    Author Photo

    Dechert attorneys analyze six years of patent owners' preliminary responses to inter partes review petitions to determine whether the elimination of the presumption favoring the petitioner as to preinstitution testimonial evidence affected the usefulness of expert testimony in responses.

  • Rebuttal

    Double-Patenting Ruling Shows Terminal Disclaimers' Value

    Author Photo

    While a recent Law360 guest article seems to argue that the Federal Circuit’s Cellect decision last year robs patent owners of lawful patent term, the ruling actually identifies how terminal disclaimers are the solution to the problem of obviousness-type double patenting, say Jane Love and Robert Trenchard at Gibson Dunn.

  • Series

    Swimming Makes Me A Better Lawyer

    Author Photo

    Years of participation in swimming events, especially in the open water, have proven to be ideal preparation for appellate arguments in court — just as you must put your trust in the ocean when competing in a swim event, you must do the same with the judicial process, says John Kulewicz at Vorys.

  • How Courts Are Interpreting Fed. Circ. IPR Estoppel Ruling

    Author Photo

    In the year since the Federal Circuit’s Ironburg ruling, which clarified the scope of inter partes and post-grant review estoppel, district court decisions show that application of IPR or PGR estoppel may become a resource-intensive inquiry, say Whitney Meier Howard and Michelle Lavrichenko at Venable.

  • Should NIL Collectives Be Allowed Tax-Favored Status?

    Author Photo

    Arguments are being made for and against allowing organizations to provide charitable contribution tax deductions for donations used to compensate student-athletes, a practice with impacts on competition for student-athletes and overall tax fairness, but ultimately it is a question for Congress, say Andres Castillo and Barry Gogel at the University of Maryland School of Law.

  • What 100 Federal Cases Suggest About Changes To Chevron

    Author Photo

    With the U.S. Supreme Court poised to overturn or narrow its 40-year-old doctrine of Chevron deference, a review of 100 recent federal district court decisions confirm that changes to the Chevron framework will have broad ramifications — but the magnitude of the impact will depend on the details of the high court's ruling, say Kali Schellenberg and Jon Cochran at LeVan Stapleton.

  • Patent Damages Jury Verdicts Aren't Always End Of The Story

    Author Photo

    Recent outcomes demonstrate that patent damages jury verdicts are often challenged and are overturned approximately one-third of the time, and successful verdict challenges typically occur at the appellate level and concern patent validity and infringement, say James Donohue and Marie Sanyal at Charles River.

  • Manufacturers Should Pay Attention To 'Right-To-Repair' Laws

    Author Photo

    Oregon’s recently passed "right-to-repair" statute highlights that the R2R movement is not going away, and that manufacturers of all kinds need to be paying attention to the evolving list of R2R statutes in various states and consider participating in the process, says Courtney Sarnow at Culhane.

  • Why High Court May Have Rejected IP Obviousness Appeal

    Author Photo

    Attorneys at Womble Bond analyze possible reasons the U.S. Supreme Court rejected Vanda Pharmaceuticals' request to review the Federal Circuit’s reasonable expectation of success standard for determining obviousness, including that the court was unpersuaded by the company's argument that Amgen v. Sanofi places a bind on drug developers.

  • Opinion

    Viral Deepfakes Of Taylor Swift Highlight Need For Regulation

    Author Photo

    As the nation grapples with addressing risk from artificial intelligence use, the recent circulation of AI-generated pornographic images of Taylor Swift on the social platform X highlights the need for federal legislation to protect nonconsenting subjects of deepfake pornography, say Nicole Brenner and Susie Ruiz-Lichter at Squire Patton.

  • A Guide To Using The DTSA For Misappropriation Recourse

    Excerpt from Practical Guidance
    Author Photo

    Nicholas Armington at Mintz explains the ins and outs of drafting a misappropriation complaint under the Defend Trade Secrets Act, and how and why companies should think strategically about federal and state law when filing a claim.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!